Literature DB >> 11429052

Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations.

I Hanamura1, S Iida, Y Akano, Y Hayami, M Kato, K Miura, S Harada, S Banno, A Wakita, H Kiyoi, T Naoe, S Shimizu, S I Sonta, M Nitta, M Taniwaki, R Ueda.   

Abstract

Chromosome 14q +, which represents a chromosomal rearrangement involving the immunoglobulin heavy chain gene (IgH) locus, is a genetic hallmark of human multiple myeloma (MM). Here, we report the identification of (14;20)(q32;q11) chromosomal translocations found in MM cells. Double color fluorescence in situ hybridization analyses pinpointed the breakpoints at the 20q11 locus in two MM cell lines within a length of at most 680 kb between the KIAA0823 and MAFB gene loci. Among the transcribed sequences in the vicinity of the breakpoints, an ectopic expression of the MAFB gene, which is located at 450 - 680 kb telomeric to one of the breakpoints and encodes a member of the MAF family basic region / leucine zipper transcription factor, was demonstrated to be associated with t(14;20). This finding, together with that of a previous study describing its transforming activity, suggests that the MAFB gene may be one of the targets deregulated by regulatory elements of the IgH gene as a result of t(14;20).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429052      PMCID: PMC5926752          DOI: 10.1111/j.1349-7006.2001.tb01142.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  20 in total

1.  MafB is an inducer of monocytic differentiation.

Authors:  L M Kelly; U Englmeier; I Lafon; M H Sieweke; T Graf
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

2.  The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.

Authors:  K Nishida; A Tamura; N Nakazawa; Y Ueda; T Abe; F Matsuda; K Kashima; M Taniwaki
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

3.  Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.

Authors:  S Iida; P H Rao; M Butler; P Corradini; M Boccadoro; B Klein; R S Chaganti; R Dalla-Favera
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

4.  Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.

Authors:  M Chesi; E Nardini; L A Brents; E Schröck; T Ried; W M Kuehl; P L Bergsagel
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

5.  MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation.

Authors:  M H Sieweke; H Tekotte; J Frampton; T Graf
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

6.  A novel human multiple myeloma-derived cell line, NCU-MM-1, carrying t(2;11)(q11;q23) and t(8;22)(q24;q11) chromosomal translocations with overexpression of c-Myc protein.

Authors:  S Iida; I Hanamura; T Suzuki; T Kamiya; M Kato; Y Hayami; K Miura; S Harada; K Tsuboi; A Wakita; Y Akano; M Taniwaki; M Nitta; R Ueda
Journal:  Int J Hematol       Date:  2000-07       Impact factor: 2.490

7.  Refinement of the commonly deleted segment in myeloid leukemias with a del(20q).

Authors:  P W Wang; K Iannantuoni; E M Davis; R Espinosa; M Stoffel; M M Le Beau
Journal:  Genes Chromosomes Cancer       Date:  1998-02       Impact factor: 5.006

8.  The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.

Authors:  S Iida; P H Rao; P Nallasivam; H Hibshoosh; M Butler; D C Louie; V Dyomin; H Ohno; R S Chaganti; R Dalla-Favera
Journal:  Blood       Date:  1996-12-01       Impact factor: 22.113

9.  Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.

Authors:  M Chesi; P L Bergsagel; O O Shonukan; M L Martelli; L A Brents; T Chen; E Schröck; T Ried; W M Kuehl
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

10.  A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region.

Authors:  A J Bench; M A Aldred; S J Humphray; K M Champion; J G Gilbert; F A Asimakopoulos; P Deloukas; R Gwilliam; D R Bentley; A R Green
Journal:  Genomics       Date:  1998-05-01       Impact factor: 5.736

View more
  25 in total

1.  Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience.

Authors:  Benjamin Hebraud; Florence Magrangeas; Alice Cleynen; Valerie Lauwers-Cances; Marie-Lorraine Chretien; Cyrille Hulin; Xavier Leleu; Edwige Yon; Gerald Marit; Lionel Karlin; Murielle Roussel; Anne-Marie Stoppa; Karim Belhadj; Laurent Voillat; Laurent Garderet; Margaret Macro; Denis Caillot; Mohamad Mohty; Thierry Facon; Philippe Moreau; Michel Attal; Nikhil Munshi; Jill Corre; Stephane Minvielle; Herve Avet-Loiseau
Journal:  Blood       Date:  2015-01-30       Impact factor: 22.113

Review 2.  Genetics of multiple myeloma: another heterogeneity level?

Authors:  Jill Corre; Nikhil Munshi; Hervé Avet-Loiseau
Journal:  Blood       Date:  2015-01-27       Impact factor: 22.113

3.  The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discovery.

Authors:  Biyin Cao; Xinliang Mao
Journal:  Am J Blood Res       Date:  2011-05-25

Review 4.  Genomic complexity of multiple myeloma and its clinical implications.

Authors:  Salomon Manier; Karma Z Salem; Jihye Park; Dan A Landau; Gad Getz; Irene M Ghobrial
Journal:  Nat Rev Clin Oncol       Date:  2016-08-17       Impact factor: 66.675

Review 5.  Multiple Myeloma: Molecular Pathogenesis and Disease Evolution.

Authors:  Michael Heider; Katharina Nickel; Marion Högner; Florian Bassermann
Journal:  Oncol Res Treat       Date:  2021-11-08       Impact factor: 2.825

Review 6.  Review of Multiple Myeloma Genetics including Effects on Prognosis, Response to Treatment, and Diagnostic Workup.

Authors:  Julia Erin Wiedmeier-Nutor; Peter Leif Bergsagel
Journal:  Life (Basel)       Date:  2022-05-30

7.  VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine.

Authors:  Eric V Yang; Elise L Donovan; Don M Benson; Ronald Glaser
Journal:  Brain Behav Immun       Date:  2007-11-05       Impact factor: 7.217

Review 8.  Multistep tumorigenesis of multiple myeloma: its molecular delineation.

Authors:  Shinsuke Iida; Ryuzo Ueda
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

9.  Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.

Authors:  Bonnie K Arendt; Marina Ramirez-Alvarado; Laura A Sikkink; Jonathan J Keats; Gregory J Ahmann; Angela Dispenzieri; Rafael Fonseca; Rhett P Ketterling; Ryan A Knudson; Erin M Mulvihill; Renee C Tschumper; Xiaosheng Wu; Steven R Zeldenrust; Diane F Jelinek
Journal:  Blood       Date:  2008-06-20       Impact factor: 22.113

Review 10.  Genetic events in the pathogenesis of multiple myeloma.

Authors:  W J Chng; O Glebov; P L Bergsagel; W M Kuehl
Journal:  Best Pract Res Clin Haematol       Date:  2007-12       Impact factor: 3.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.